case submissions diagnosed as canine mast cell tumors were submitted to the Athens Veterinary Diagnostic Laboratory. Eighteen of these submissions were from dogs of the Shar-Pei breed. Of these 18 cases, 5 occurred in Shar-Peis less than 2 years of age, 4 of these were poorly differentiated, and 4 out of 5 occurred in the inguinal or preputial area. Three mast cell tumors (grade I) occurred in Boxer/ Boxer cross dogs, and 2 tumors (grade II) occurred in Cocker Spaniels younger than 2 years of age. Of the 23,315 histopathology submissions, only 164 were from Shar-Peis and 57 of these dogs were under 2 years of age.
Never in recent history has a dog breed grown in popularity (and in population) in such a short period of time as the Chinese Shar-Pei. In 1973, the Shar-Pei was considered by The Guinness Book of Records to be the rarest dog in the world. 10 Registration figures show that the Chinese Shar-Pei Club of America has registered 75,000 individual Shar-Peis and 47,000 litters. 10 As of August 1992, the breed began competing in the nonsporting group at American Kennel Club (AKC)-licensed shows. They have become the 134th recognized AKC breed. 10 Over the past 2 years, the Athens Veterinary Diagnostic Laboratory has received 802 submissions in which canine mast cell tumor (MCT) was the diagnosis. Mast cell tumors generally occur in dogs as solitary masses in mature animals. 6, 9 In this paper, I report the breed variation in age of incidence, frequency, and location of MCT, with special emphasis on the Shar-Pei breed, in cases submitted to the Athens Veterinary Diagnostic Laboratory. The data include 18 cases of MCT diagnosed in Shar-Peis. Five of these cases were in dogs less than 2 years of age.
Materials and methods
The cases presented were received as routine submissions to the Athens Veterinary Diagnostic Laboratory from referring veterinarians in Georgia from July 1991 through June 1993. All the samples were formalin fixed prior to submission. The tissue was embedded in paraffin, sectioned at 5 µm, and stained with hematoxylin and eosin and toluidine blue. The samples were graded by pathologists at the Athens Veterinary Diagnostic Laboratory using Patnaik's grading system. 7 All tumors occurring in Shar-Peis and dogs under 2 yr of age were reviewed by the author. Follow-up status of all Shar-Peis was obtained by phone contact with the submitting veterinarian.
From the Athens Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Received for publication April 22, 1994. During fiscal years 1991 and 1992, there were 31,153 canine submissions to the Laboratory, of which 23,315 involved histopathology. During this period, there were 250 Shar-Pei submissions, of which 164 were for histopathological evaluation. Seventy-five of these 250 submissions were from Shar-Peis under 2 years of age. Only 57 histopathology submissions were from Shar-Peis under 2 years of age. The total number of submissions per breed for histopathology are listed in Table 1 .
The breeds recorded and site of occurrence are those listed on the submission forms by the submitting veterinarians. All cross-breeds (Peekapoo, Cockapoo, Labrador Retriever cross, etc.) are included in a category of mixed unless otherwise noted. No specimens were identified as coming from Bull Terriers. Data from Pit Bull Terriers were kept separate from data from American Staffordshire Terriers.
Results
A summary of the breeds of the 802 cases of mast cell tumors (MCT) is presented in Table 1 . There was no sex predilection. Of the MCT in dogs less than 2 years of age, 5 occurred in Shar-Peis, 3 in Boxer/Boxer crosses, 1 in a Bulldog, 2 in Cocker Spaniels, and 2 each in Golden Retrievers, Terrier crosses, and Shih Tzus. The MCT from the breeds other than Shar-Peis 2 years of age or younger were grade I (5) or Grade II (2) A summary of the 18 cases of MCT occurring in Shar-Peis is presented in Table 2 . Although the pedigree of the individual animals was not available, all the Shar-Peis were obtained from separate breeders. The possibility of common ancestry could not be determined from the information available. The tumors that recurred in the Shar-Peis recurred within 3 months. The Shar-Pei breed had the youngest median and mean age for MCT. Table 3 summarizes the location and grade of the 802 MCT cases. The most common sites were the mammary gland region (86 tumors), multiple skin sites (40), and scrotum (37). Most tumors were well differentiated (grade I). The left thorax was a more common Breeds from which fewer than 5 case submissions were diagnosed as an MCT were Alaskan Malamute, Australian Shepherd, Belgian Sheepdog, Bichon Frise, Border Collie, Bouvier des Flandres, Brittany Spaniel, Bull Mastiff, Cairn Terrier, Chihuahua, Fox Terrier, Gordon Setter, Great Dane, Greyhound, hound, Irish Setter, Jack Russell Terrier, Maltese, Old English Sheepdog, Pekingese, Pharoah Hound, Rottweiler, Siberian Husky, Spitz, and West Highland White Terrier. site of occurrence than the right thorax. In the Shar-Pei breed, there was no one site predilection, but 3 tumors occurred in the inguinal area, 2 in the ventral chest (mammary gland region), and 2 on the left hock. Also, 8 of the total 73 MCT of grade III occurred in Shar-Peis (11% of all MCT).
Discussion
The 18 cases of Shar-Pei mast cell tumors described in this paper represent an increased prevalence not reported before for this breed. Thirty-five years ago, the most common breeds for 100 cases of MCT were reported as Boston Terrier (19), Boxer (17), Terrier cross (12), mixed (8), Cocker Spaniel (7), Fox Terrier (5), Bull Terrier (4), and Scottish Terrier (3). 4 In the cases reported here, the most common breeds were mixed breed (125), Boxer (92), Labrador Retriever (107), Golden Retriever (61), Cocker Spaniel (41), Boston Terrier (33), Pit Bull Terrier (41), and Shar-Pei (18). This difference may reflect both incidence in breeds and popularity of the breeds for this area of the United States in the past 10 years. The incidence in Boxers (second place) and Cocker Spaniels (fifth place) have remained the same, and Pit Bull Terriers remained the same as Bull Terriers (seventh place).
A higher incidence of MCT has been reported in dogs of Bulldog ancestry such as Boxers, Boston Terriers, English Bulldogs, and Bull Terriers. 1, 8, 11 In the present cases reported, 3 of the top 8 breeds listed are of Bulldog ancestry. There were only 5 submissions from American Staffordshire Terriers, which some people call "Pit Bulls." There are no reliable pedigree records for the Shar-Pei before it came to the United States. The genetic makeup of this breed is conjectural. Some reports suggest that the Shar-Pei is a mixture of Chow and Mastiff-type dogs. 10 The average age of dogs with MCT has been reported to be 8. 2-8.5 years. 2,11 In the examples reported here, the average age for Shar-Peis with MCT was 4.3 years, for Boxers, 6.9 years, and for the other breeds related to Bulldogs, 7.7 years. Thus, the age at which the tumor occurs in Shar-Peis is more similar to that of Boxers than to that of the other Bulldog-related breeds.
The most common sites for MCT in dogs are the skin of the trunk and perineal region (50%) and the skin of the extremities (40%). 5, 11 In only about 25% of the reported cases have there been multiple tumors. 1, 11 Some reports suggest that MCT in the preputial, inguinal, and perineal areas are more apt to be malignant; this may be true for In the present study, 10 of the 18 cases occurring in Shar-Peis were from the trunk or perineal region (33%), 5 (27%) were found on the extremities, and 4 (22%) were from the inguinal/ preputial region. In these Shar-Peis, the inguinal and preputial areas were affected only in animals 2 years old or younger.
Several possible causes have been suggested for MCT: a viral etiology, hereditary factors, and a deficiency of has been identified. A histologic system for grading MCT has been in use since 1967 and has been recently upgraded 5, 7 Mast cell tumors can be placed into grade I (well differentiated), grade II (moderately differentiated), or grade III (poorly differentiated) based on their histopathologic appearance. All of the MCT occurring in the 5 Shar-Peis under 2 years of age were poorly differentiated (grade III), and 6 of the 11 MCT in Shar-Peis 3 years old or older were well differentiated (grade I). MCT in Boxers generally are well differentiated (grade I). 5 In the present study, the MCT from the non-Shar-Pei dogs less than 2 years of age also were well differentiated (5 tumors) to moderately differentiated (2 tumors).
The recurrence time for MCT has been reported to be between 2 weeks and 1 year for 17% of the cases. 4 In the 18 cases of MCT in Shar-Peis, the recurrence time could not be determined for all the masses. One mass in a 7-year-old animal recurred within 3 months. One mass in a 1.5-year-old dog recurred and was removed twice before the animal was euthanized. The 4-month-old dog was returned to the breeder, and 2 of the 1.5-year-old dogs were accidentally killed by cars. The 2-year-old dog with multiple masses was euthanized. There has not been a recurrence in the remaining animals to the knowledge of the referring veterinarians. The genetic relationships among the affected dogs could not be determined, but the animals were from different breeders and from different areas of the state. However, because of the rarity of this breed, the possibility of some common ancestry cannot be ruled out.
This report updates the incidence of canine mast cell tumors in 1 area of the United States. There appears to be an increased incidence of MCT in the Shar-Pei breed with poorly differentiated tumors (grade III) more common in Shar-Peis under 2 years of age. The poorly differentiated tumor (grade III) in young Shar-Peis is likely to recur within a short period of time.
